| Product | Country | Indication | Pre-Clinical | Clinical Trials | Reg. Filing | Approval/RG |
| Escozine® | Dominican Republic | SARS-CoV-2 (COVID-19) | ||||
| Escozine® | United States | SARS-CoV-2 (COVID-19) | ||||
| Escozine® GNP-1 | United States | Ovarian Cancer | ||||
| Escozine® GNP-1 | Dominican Republic | General Cancer | ||||
| Escozine® GNP-1 | United States | Bladder Cancer |
